Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 3
1999 4
2000 2
2001 5
2002 3
2003 4
2004 6
2005 9
2006 2
2007 5
2008 6
2009 11
2010 8
2011 6
2012 7
2013 11
2014 9
2015 15
2016 16
2017 13
2018 18
2019 14
2020 17
2021 33
2022 33
2023 21
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

252 results

Results by year

Filters applied: . Clear all
Page 1
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis.
Trougakos IP, Terpos E, Alexopoulos H, Politou M, Paraskevis D, Scorilas A, Kastritis E, Andreakos E, Dimopoulos MA. Trougakos IP, et al. Among authors: paraskevis d. Trends Mol Med. 2022 Jul;28(7):542-554. doi: 10.1016/j.molmed.2022.04.007. Epub 2022 Apr 21. Trends Mol Med. 2022. PMID: 35537987 Free PMC article. Review.
Editorial.
Paraskevis D, Ayouba A, Peeters M. Paraskevis D, et al. Infect Genet Evol. 2016 Dec;46:149. doi: 10.1016/j.meegid.2016.11.017. Infect Genet Evol. 2016. PMID: 27914559 No abstract available.
Pre-Exposure Prophylaxis for HIV: Evidence and Perspectives.
Nikolopoulos GK, Christaki E, Paraskevis D, Bonovas S. Nikolopoulos GK, et al. Among authors: paraskevis d. Curr Pharm Des. 2017;23(18):2579-2591. doi: 10.2174/1381612823666170329145053. Curr Pharm Des. 2017. PMID: 28356043 Review.
Real-world Effectiveness of Molnupiravir and Nirmatrelvir/Ritonavir as Treatments for COVID-19 in Patients at High Risk.
Paraskevis D, Gkova M, Mellou K, Gerolymatos G, Psalida N, Gkolfinopoulou K, Kostaki EG, Loukides S, Kotanidou A, Skoutelis A, Thiraios E, Saroglou G, Zografopoulos D, Filippou D, Mossialos E, Zaoutis T, Gaga M, Tsiodras S, Antoniadou A. Paraskevis D, et al. J Infect Dis. 2023 Dec 20;228(12):1667-1674. doi: 10.1093/infdis/jiad324. J Infect Dis. 2023. PMID: 37565522 Free PMC article.
Primate immunodeficiency virus classification and nomenclature: Review.
Foley BT, Leitner T, Paraskevis D, Peeters M. Foley BT, et al. Among authors: paraskevis d. Infect Genet Evol. 2016 Dec;46:150-158. doi: 10.1016/j.meegid.2016.10.018. Epub 2016 Oct 24. Infect Genet Evol. 2016. PMID: 27789390 Free PMC article. Review.
Recent Advances in Antiretroviral Agents: Potent Integrase Inhibitors.
Psichogiou M, Poulakou G, Basoulis D, Paraskevis D, Markogiannakis A, Daikos GL. Psichogiou M, et al. Among authors: paraskevis d. Curr Pharm Des. 2017;23(18):2552-2567. doi: 10.2174/1381612823666170329142059. Curr Pharm Des. 2017. PMID: 28356041 Review.
Overview of Mpox Outbreak in Greece in 2022-2023: Is It Over?
Mellou K, Tryfinopoulou K, Pappa S, Gkolfinopoulou K, Papanikou S, Papadopoulou G, Vassou E, Kostaki EG, Papadima K, Mouratidou E, Tsintziloni M, Siafakas N, Florou Z, Katsoulidou A, Sapounas S, Sourvinos G, Pournaras S, Petinaki E, Goula M, Paparizos V, Papa A, Zaoutis T, Paraskevis D. Mellou K, et al. Among authors: paraskevis d. Viruses. 2023 Jun 16;15(6):1384. doi: 10.3390/v15061384. Viruses. 2023. PMID: 37376683 Free PMC article. Review.
252 results